Genmab Seen Dropping 10% After Losing J&J Arbitration Case: Analysts

(PLX AI) – Genmab shares may drop 10% at the open after the company lost an arbitration case against Johnson & Johnson.Genmab was in binding arbitration of two matters arising under its license agreement with Janssen Biotech relating to daratumumab, …